您使用提示模式 关闭

560900 - JPM CSI Brand Name Drug Industry ETF (CNY) (CNE100005B86)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

全选 清除所有
 
(%)
CNE100005B86
560900 ISIN
交易所交易基金 (ETF)
基金类型
J.P. Morgan Asset Management
提供商
-
每股资产净值
2022-05-09
成立日期
1 每年的次数
股息的支付
CEOXXX
CFI
560900
代码
Formed
Status
Equity
投资项目
Healthcare
部门
China
地区分布
CSI Innovative Drug Industry Index
基准
0.4 %
总成本比率
Physical
复制方法
否
UCITS
Passive (Index)
Management Style

最新数据在
添加比较项目
从
至
ADD-IN
Cbonds 加载项 API
债券数据 API

报价 (560900)

探索最全面的数据库

1 000 000

债券

80 234

股票

167 970

ETF & Funds

8万

指数

以最有效的方式跟踪您的投资组合

  • 债券筛选器
  • 观察列表
  • Excel 附加组件
请求访问

价格动态的变化

Fund profile

The JPM CSI Brand Name Drug Industry ETF seeks to replicate as closely as possible the price and yield performance of the CSI Innovative Drug Industry Index by investing in a portfolio comprised primarily of Chinese pharmaceutical companies

560900 profile

The JPM CSI Brand Name Drug Industry ETF (CNY) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in China. The J.P. Morgan Asset Management fund’s base currency is CNY and the share class was registered 09.05.2022 with unique ISIN - CNE100005B86. Main exchange is Shanghai SE and ticker symbol is 560900. The total expense ratio is 0.4%. The JPM CSI Brand Name Drug Industry ETF (CNY) pays dividends 1 time(s) per year.

其他 ETF 和基金提供商

相关 ETF 和基金

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} 百万
    资产净值
    {{ item.expense_ratio }}
    总成本比率
你必须 注册 才能获得访问权